ID   YCMi001-B-1
AC   CVCL_A9YY
DR   hPSCreg; YCMi001-B-1
DR   Wikidata; Q102115140
RX   PubMed=32798916;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; 3546; F8; Unexplicit_corrected; Ex8-22del; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=32798916).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9YX ! YCMi001-B
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 7
//
RX   PubMed=32798916; DOI=10.1016/j.scr.2020.101948;
RA   Sung J.J., Park S., Choi S.-H., Kim J., Cho M.S., Kim D.-W.;
RT   "Generation of a gene edited hemophilia A patient-derived iPSC cell
RT   line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII
RT   using CRISPR/Cas9.";
RL   Stem Cell Res. 48:101948-101948(2020).
//